clinical trials

Combo of Roche's Tecentriq and Exelixis' Cabometyx fails another trial, this time in lung cancer
Fierce Pharma
Sun, 12/11/22 - 01:20 pm
Roche
Tecentriq
Exelixis
Cabometyx
clinical trials
non small cell lung cancer
Chasing Gilead, AstraZeneca-Daiichi lay down phase 2 breast cancer data for antibody-drug conjugate
Fierce Biotech
Fri, 12/9/22 - 10:46 am
AstraZeneca
Daiichi Sankyo
breast cancer
antibody-drug conjugate
clinical trials
Gilead Sciences
Autolus announces primary endpoint met in FELIX trial, prices public offering
Pharmaphorum
Fri, 12/9/22 - 10:45 am
Autolus
ALL
clinical trials
obe-cel
funding
Exelixis drug fails PhIII lung cancer trial with Cabometyx and Tecentriq combo
Endpoints
Fri, 12/9/22 - 10:39 am
Exelixis
Cabometyx
Tecentriq
metastatic non-small cell lung cancer
clinical trials
Gilead lands new cell therapy for Kite in $225M Arcellx deal
Fierce Biotech
Fri, 12/9/22 - 10:37 am
Gilead Sciences
Kite Pharma
Arcellx
clinical trials
Multiple Myeloma
cell therapy
JNJ
Legend Biotech
Replimune’s melanoma success looks more than skin deep
EP Vantage
Fri, 12/9/22 - 10:34 am
Replimune
melanoma
clinical trials
RP1
Novartis' iptacopan meets PhIII test in fight against rare blood disease
Endpoints
Thu, 12/8/22 - 10:37 am
Novartis
clinical trials
paroxysmal nocturnal hemoglobinuria
iptacopan
Relmada rails against depression data both 'implausible' and 'unplausible' in latest phase 3 flunk
Fierce Biotech
Thu, 12/8/22 - 10:20 am
Relmada
REL-1017
depression
clinical trials
Novartis’ Kisqali Hits Mark in Mid-Stage Breast Cancer Trial
BioSpace
Wed, 12/7/22 - 11:39 pm
Novartis
Kisqali
breast cancer
clinical trials
COVID trials marked by lack of women, Black and Asian subjects
Medical Marketing and Media
Wed, 12/7/22 - 11:33 pm
clinical trials
vaccines
COVID-19
clinical trial diversity
With a new No. 1, Avrobio hopes to get investors back on gene therapy bandwagon
Fierce Biotech
Wed, 12/7/22 - 10:00 am
Avrobio
clinical trials
AVR-RD-02
Gaucher disease
Neurocrine's $50M bet on Idorsia drug flames out in second PhII
Endpoints
Wed, 12/7/22 - 09:58 am
Neurocrine
Idorsia
clinical trials
NBI-827104
epileptic encephalopathy
Prometheus Biosciences Catapults 176% On Promising Results In UC and Crohn's
Investors Business Daily
Wed, 12/7/22 - 09:40 am
Prometheus Biosciences
clinical trials
ulcerative colitis
Crohn’s disease
Vanda reports data from Phase II acute performance anxiety therapy trial
Clinical Trials Arena
Mon, 12/5/22 - 10:49 pm
Vanda Pharmaceuticals
clinical trials
VQW-765
performance anxiety
anxiety
The business of clinical trials is booming. Private equity has taken notice.
Medical Marketing and Media
Mon, 12/5/22 - 10:41 pm
clinical trials
In Face of Multiple Patent Cliffs, Novartis' Prostate Cancer Drug Shows Promise
BioSpace
Mon, 12/5/22 - 10:58 am
Novartis
prostate cancer
Pluvicto
clinical trials
patents
patent cliff
UroGen reports data from Phase IIb trial of bladder cancer treatment
Clinical Trials Arena
Mon, 12/5/22 - 10:51 am
Urogen
clinical trials
UGN-102
bladder cancer
Vaxxinity’s Phase III Covid-19 booster trial meets endpoints
Clinical Trials Arena
Mon, 12/5/22 - 10:50 am
Vaxxinity
UB-612
clinical trials
COVID-19
vaccines
Amgen to push latecomer obesity drug into midstage testing
Pharmaphorum
Sun, 12/4/22 - 01:26 pm
Amgen
Novo Nordisk
Eli Lilly
obesity
clinical trials
AMG 133
Amid Buyout Buzz, Mirati Pushes Phase III NSCLC Study to Final Analysis
BioSpace
Sun, 12/4/22 - 01:17 pm
Mirati Therapeutics
clinical trials
M&A
non-small cell lung cancer
sitravantinib

Pages